Adjuvant Hormonotherapy (Tamoxifen Versus Medro-Xyprogesterone Acetate Versus Control) in Women With Endometrial Cancer, Figo Stage I and II
Journal of Cancer Research and Clinical Oncology - Germany
doi 10.1007/bf02580300
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 1986
Authors
Publisher
Springer Science and Business Media LLC